NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed on AceCGT Life Sciences Limited as the exclusive distributor of its SelectMDx for Prostate Cancer test in Hong Kong and Macao.

Under the terms of their agreement, AceCGT will send patient samples for analysis to MDxHealth's ISO-certified clinical diagnostic lab in Nijmegen, The Netherlands for analysis. Additional terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.